Rachel Bender Ignacio

1.2k total citations
40 papers, 424 citations indexed

About

Rachel Bender Ignacio is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Rachel Bender Ignacio has authored 40 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 15 papers in Epidemiology and 13 papers in Virology. Recurrent topics in Rachel Bender Ignacio's work include HIV/AIDS Research and Interventions (15 papers), HIV Research and Treatment (12 papers) and Viral-associated cancers and disorders (9 papers). Rachel Bender Ignacio is often cited by papers focused on HIV/AIDS Research and Interventions (15 papers), HIV Research and Treatment (12 papers) and Viral-associated cancers and disorders (9 papers). Rachel Bender Ignacio collaborates with scholars based in United States, Peru and South Africa. Rachel Bender Ignacio's co-authors include Ann Duerr, Michael Boeckh, Sayan Dasgupta, Helen Y. Chu, Javier R. Lama, David G. Rosenthal, Corey Casper, Joshua T. Schiffer, Jennifer Chang and Wendy S. Armstrong and has published in prestigious journals such as Blood, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Rachel Bender Ignacio

33 papers receiving 418 citations

Peers

Countries citing papers authored by Rachel Bender Ignacio

Since Specialization

Citations

This map shows the geographic impact of Rachel Bender Ignacio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Bender Ignacio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Bender Ignacio more than expected).

Fields of papers citing papers by Rachel Bender Ignacio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Bender Ignacio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Bender Ignacio. The network helps show where Rachel Bender Ignacio may publish in the future.

Co-authorship network of co-authors of Rachel Bender Ignacio

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Bender Ignacio. A scholar is included among the top collaborators of Rachel Bender Ignacio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Bender Ignacio. Rachel Bender Ignacio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Healthcare provider perspectives on integrating HIV care into cancer centers in Malawi, South Africa, Uganda, and Zimbabwe 2025 ·Translational Oncology ·Michalina A. Montaño, (unknown), (unknown), (unknown), Agatha Bula, Maganizo Chagomerana, Margaret Borok, (unknown), Maureen Joffe, Rachel Bender Ignacio, Ntokozo Ndlovu	0
2	Promoting Human Immunodeficiency Virus Syndemic Care in Health Professions Education: Linking Workforce Demands to the Aspirations of a Rising Generation 2025 ·Clinical Infectious Diseases ·(unknown), Lydia Barakat, Elizabeth M Sherman, (unknown), (unknown), Joseph S. Cervia, Marwan Haddad, Vincent Guilamo‐Ramos, (unknown), (unknown), Rachel Bender Ignacio	0
3	Long-acting Injectable Containing Lopinavir Eliminates Reliance on Ritonavir Pharmacokinetic Enhancement 2025 ·The Journal of Infectious Diseases ·(unknown), Charles Flexner, Zachary R. Stephen, Edward P. Acosta, Rachel Bender Ignacio, Rodney J. Y. Ho	0
4	Observational study of effects of HIV acquisition and antiretroviral treatment on biomarkers of systemic immune activation 2024 ·PLoS ONE ·(unknown), (unknown), Ana Gervassi, Rachel Bender Ignacio, Delia Pinto-Santini, Germán G. Gornalusse, Urvashi Pandey, Florian Hladik, Paul T. Edlefsen, Javier R. Lama, Ann Duerr, Lisa M. Frenkel	3
5	Strategies for Expediting Clinical Trials in the Next Public Health Emergency 2023 ·JAMA Health Forum ·Boghuma K Titanji, David R. Boulware, Rachel Bender Ignacio	3
6	Characterizing HIV status documentation among cancer patients at regional cancer centers in Malawi, Zimbabwe, and South Africa 2023 ·Infectious Agents and Cancer ·Michalina A. Montaño, (unknown), Ntokozo Ndlovu, Margaret Borok, Agatha Bula, Maureen Joffe, Rachel Bender Ignacio, Maganizo Chagomerana	1
7	Dynamic immune markers predict HIV acquisition and augment associations with sociobehavioral factors for HIV exposure 2022 ·iScience ·Rachel Bender Ignacio, Sayan Dasgupta, (unknown), Urvashi Pandey, Siavash Pasalar, (unknown), Florian Hladik, Germán G. Gornalusse, Javier R. Lama, Ann Duerr	4
8	Mycobacterium tuberculosis infection, immune activation, and risk of HIV acquisition 2022 ·PLoS ONE ·Rachel Bender Ignacio, (unknown), (unknown), (unknown), (unknown), Ethan Valinetz, Simon C. Mendelsohn, Thomas J. Scriba, Mark Hatherill, Holly Janes, Gavin Churchyard, Susan Buchbinder, Ann Duerr, Javeed A. Shah, Thomas R. Hawn	2
9	1063. Female sex and SARS-CoV-2 Serostatus Predict Nasopharyngeal RNA Clearance during Early COVID-19 2022 ·Open Forum Infectious Diseases ·Carlee Moser, Jonathan Z. Li, Joseph J. Eron, Evgenia Aga, Eric S. Daar, David A. Wohl, (unknown), Arzhang Cyrus Javan, Rachel Bender Ignacio, Prasanna Jagannathan, Justin Ritz, Scott F. Sieg, Urvi M. Parikh, Michael D. Hughes, Judith S. Currier, Davey M. Smith, Kara W Chew	0
10	Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses 2021 ·mBio ·Judith M. White, Joshua T. Schiffer, Rachel Bender Ignacio, Shuang Xu, Denis E. Kainov, Aleksandr Ianevski, Tero Aittokallio, Matthew B. Frieman, Gene G. Olinger, Stephen J. Polyak	42
11	Initiation of Antiretroviral Therapy during Primary HIV Infection: Effects on the Latent HIV Reservoir, Including on Analytic Treatment Interruptions 2021 ·PubMed ·Daniel B. Reeves, (unknown), Rachel Bender Ignacio	14
12	Association between live childhood vaccines and COVID-19 outcomes: a national-level analysis 2021 ·Epidemiology and Infection ·Chikara Ogimi, Pingping Qu, Michael Boeckh, Rachel Bender Ignacio, Sahar Z. Zangeneh	17
13	A phase 1b/pharmacokinetic trial of PTC299, a novel post-transcriptional VEGF inhibitor, for AIDS-related Kaposi’s sarcoma: AIDS Malignancy Consortium trial 059 2020 ·UNC Libraries ·David M. Aboulafia, Anil Tulpule, Bruce J. Dezube, Dirk P. Dittmer, Rachel Bender Ignacio, (unknown), Ronald T. Mitsuyasu, Michelle A. Rudek, Joseph A. Sparano, Richard F. Ambinder, (unknown), Susan E. Krown, Elizabeth Y. Chiao, Erin Reid, Robert A. Baiocchi, Jeannette Y. Lee, Anthony B. Eason, Bruce Shiramizu	0
14	Comprehensive viromewide antibody responses by systematic epitope scanning after hematopoietic cell transplantation 2019 ·Blood ·Rachel Bender Ignacio, Sayan Dasgupta, Terry Stevens‐Ayers, Tomasz Kula, Joshua A. Hill, Stephanie J. Lee, Marco Mielcarek, Ann Duerr, Stephen J. Elledge, Michael Boeckh	8
15	HIV pretreatment drug resistance among cisgender MSM and transgender women from Lima, Peru 2019 ·Journal of the International AIDS Society ·(unknown), Javier R. Lama, Ann Duerr, Hugo Sánchez, Robinson Cabello, (unknown), Patricia Segura, Sari L. Reisner, Kenneth H. Mayer, James I. Mullins, Rachel Bender Ignacio	13
16	T Cell Immunity to Varicella-Zoster Virus in the Setting of Advanced HIV and Multiple Varicella-Zoster Virus Recurrences 2016 ·Viral Immunology ·Rachel Bender Ignacio, Meena S. Ramchandani, Kerry J. Laing, Christine Johnston, David M. Koelle	5
17	Patterns of human herpesvirus-8 oral shedding among diverse cohorts of human herpesvirus-8 seropositive persons 2016 ·Infectious Agents and Cancer ·Rachel Bender Ignacio, Jason D. Goldman, Amalia Magaret, Stacy Selke, Meei‐Li Huang, Soren Gantt, Christine Johnston, Warren Phipps, Joshua T. Schiffer, Richard A. Zuckerman, R. Scott McClelland, Connie Celum, Lawrence Corey, Anna Wald, Corey Casper	16
18	Oral and Vaginal Tenofovir for Genital Herpes Simplex Virus Type 2 Shedding in Immunocompetent Women: A Double-Blind, Randomized, Cross-over Trial 2015 ·The Journal of Infectious Diseases ·Rachel Bender Ignacio, (unknown), Amalia Magaret, (unknown), Claire E. Stevens, Meei‐Li Huang, Stacy Selke, Christine Johnston, Jeanne Marrazzo, Anna Wald	13
19	Hemophagocytic Lymphohistiocytosis Secondary to Human Immunodeficiency Virus-Associated Histoplasmosis 2015 ·Open Forum Infectious Diseases ·(unknown), David G. Rosenthal, Rachel Bender Ignacio, Helen Y. Chu	27
20	Influence of providers and nurses on completion of non-targeted HIV screening in an urgent care setting 2014 ·AIDS Research and Therapy ·Rachel Bender Ignacio, (unknown), Melinda C. Power, Jeffrey Douaiher, (unknown), (unknown), Valerie E. Stone	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact